| PDA0207 | Interferon-a modulates the host glycosylation machinery during treated HIV infection | Poster exhibition | A24 |
| OAA0304 | Priming with DNA expressing trimeric V1V2A244 alters the immune hierarchy and favors the development of V2-specific HIV antibodies in rhesus macaques | Oral abstract session with live Q&A | A25 |
| OAA0305 | Sequence and structure guided HIV-1 clade C trimeric immunogen design to induce neutralizing and V1V2 directed antibody responses | Oral abstract session with live Q&A | A25 |
| OAALB0101 | Induction of cross-neutralizing antibodies and protection from heterologous tier-2 SHIV challenge by an mRNA-based vaccine in macaques | Oral abstract session with live Q&A | A25 |
| OAALB0104 | Vaccination against HIV-1 with interbilayer cross-linked multilamellar vesicles carrying SOSIP trimer | Oral abstract session with live Q&A | A25 |
| OAALB0102 | HIV envelope BG505 SOSIP immunization induces autologous virus and CD4 binding site-specific B cell lineage antibody precursor responses in infant rhesus macaques | Oral abstract session with live Q&A | A26 |
| OAA0306 | Protective efficacy of a vaccine inducing Gag/Vif-specific CD8+ T but not CD4+ T cells against repeated intrarectal low-dose SIVmac239 challenges | Oral abstract session with live Q&A | A27 |
| OAA0302 | Multivariant HIV-1 infection in infants with broadly neutralizing plasma antibodies: Implication for polyvalent vaccines | Oral abstract session with live Q&A | A28 |
| OAA0307 | Co-immunization of DNA and protein in the same anatomical sites induces superior protective immune responses against SHIV challenge | Oral abstract session with live Q&A | A28 |
| PDA0104 | Association of age and cervical cancer screening results in 11 urban health centers in Lusaka, Zambia | Poster exhibition | A29 |